Sign up to save your podcasts
Or
Share Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Chemoradiotherapy vs Chemotherapy for Pancreatic Cancer
Interview with Pascal Hammel, MD, author of Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial
View all episodes
By JAMA Network
4.6
162162 ratings
Interview with Pascal Hammel, MD, author of Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial
More shows like JAMA Author Interviews
View all
Fresh Air
38,522 Listeners
Hidden Brain
43,542 Listeners
The Moth
27,107 Listeners
JAMA Editors' Summary
135 Listeners
NEJM This Week
327 Listeners
Emergency Medicine Cases
546 Listeners
AFP: American Family Physician Podcast
708 Listeners
JAMA Clinical Reviews
504 Listeners
Science Friday
6,440 Listeners
Mayo Clinic Talks
297 Listeners
Frankly Speaking About Family Medicine
267 Listeners
The Curbsiders Internal Medicine Podcast
3,377 Listeners
JAMA Psychiatry Author Interviews
20 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Cardiology Author Interviews
7 Listeners
JAMA Surgery Author Interviews
7 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
The Curious Clinicians
378 Listeners